Abk�rzung zur Hauptnavigation Abk�rzung zu den Newsmeldungen Abk�rzung zu den Topstories  
  Barrierefreiheit    Kontakt MedUni Wien    Intranet    MedUni Wien - Shop    Universitätsbibliothek    Universitätsklinikum AKH Wien  
 
ccc_logo_en.gif
 
AKH Wien
 
 
Hauptnavigation
  • Livestream 2021
  • Home
  • Über das CCC
    • Allgemeines
    • Leitung der Organisationseinheit
    • CCC-Office Team
    • Kliniken und Partner
    • Qualitätsmanagement
    • Kontakt
  • PatientInnen
    • Covid-19
    • Allgemeines
    • Cancer School
    • Terminvereinbarung
    • Pflegeambulanz
    • PatientInnenvertretung
    • Links
  • Klinischer Bereich
    • Allgemeines
    • CCC Tumorboards
  • Wissenschaft & Forschung
    • Young CCC
    • CCC-ExpertInnenvideos
    • CCC Forschungscluster
    • CCC Units
    • CCC Platforms
    • Translationale Forschung
    • CCC Best Paper Award
    • CCC-TRIO Symposium
    • Kontakt/Links
  • Lehre
    • CCC Cancer School
    • Vienna International Summer School on Clinical and Experimental Oncology - VSSO
    • CCC Excellence Lecture
    • Interdisziplinäre onkologische Ausbildung
    • Klinisch-Praktisches Jahr (KPJ)
    • PhD Programme
    • Postgraduelle Fort- und Weiterbildung
    • Information/Contact
 
 
Subnavigation
    Inhaltsbereich


    Zurück zur Übersicht
    International journal of immunogenetics. 2018 Jul 25. doi: 10.1111/iji.12380
    The influence of glucocorticoid receptor single nucleotide polymorphisms on outcome after haematopoietic stem cell transplantation.
    Norden J1,  Pearce KF2,  Irving JAE3,  Collin MP4,  Wang XN5,  Wolff D6,  Kolb HJ7,  Socie G8,  Kuzmina Z9,  Greinix H10,  Holler E11,  Rocha V12,  Gluckman E13,  Hromadnikova I14,  Dickinson AM15
    Author information
    1Haematological Sciences, Institute of Cellular Medicine, University of Newcastle upon Tyne, Newcastle upon Tyne, UK.
    2Haematological Sciences, Institute of Cellular Medicine, University of Newcastle upon Tyne, Newcastle upon Tyne, UK.
    3Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, University of Newcastle upon Tyne, Newcastle upon Tyne, UK.
    4Haematological Sciences, Institute of Cellular Medicine, University of Newcastle upon Tyne, Newcastle upon Tyne, UK.
    5Haematological Sciences, Institute of Cellular Medicine, University of Newcastle upon Tyne, Newcastle upon Tyne, UK.
    6Department of Haematology and Oncology, University of Regensburg, Regensburg, Germany.
    7Klinikum Grosshadern, III Medical Klinik, Munich, Germany.
    8Department of Haematology, St Louis Hospital, Paris, France.
    9Department of Internal Medicine I, Bone Marrow Transplantation, Medical University of Vienna, Vienna, Austria.
    10Department of Internal Medicine, Division of Haematology, Medical University of Graz, Graz, Austria.
    11Department of Haematology and Oncology, University of Regensburg, Regensburg, Germany.
    12EUROCORD, St Louis Hospital, Paris, France.
    13EUROCORD, St Louis Hospital, Paris, France.
    14Department of Molecular Biology and Cell Pathology, Third faculty of Medicine, Charles University, Prague, Czech Republic.
    15Haematological Sciences, Institute of Cellular Medicine, University of Newcastle upon Tyne, Newcastle upon Tyne, UK.
    Abstract

    Haematopoietic stem cell transplantation (HSCT) remains the only cure for most haematological malignancies, however, the mortality rate remains high. Complications after HSCT include relapse, graft versus host disease (GvHD), graft rejection and infection. Over the last few years several groups, have demonstrated that non-HLA gene polymorphisms can be predictive of outcome after HSCT. Since the glucocorticoid cortisol is pivotal in the regulation of the immune system, we decided to examine single nucleotide polymorphisms (SNPs; rs6198, rs33388 and rs33389) within the glucocorticoid receptor (GR) and correlate with HSCT outcome. The training set consisted of patients (n = 458) who underwent HSCT for acute leukaemia between 1983 and 2005. In the recipients, the absence of the ACT haplotype and absence of the T allele of rs33388 were associated with decreased OS and the absence of the ACT haplotype, the absence of the T allele of rs33388 and the presence of the ATA haplotype were associated with increased risk of relapse. In addition, the presence of the ACT haplotype in the recipient showed a trend to be associated with increased risk of chronic graft versus host disease (cGvHD). The patients in this cohort received mainly myeloablative conditioning (n = 327). The SNPs in the glucocorticoid receptor were then investigated in a validation set (n = 251) of HSCT patients transplanted for acute leukaemia from 2006. This cohort contained significantly more patients that had received reduced intensity conditioning (RIC). Some of the results could be validated in these patients. However, contrary to the training set, the absence of the haplotype ACT in the donor in this cohort was associated with increased risk of cGvHD. Differences in the conditioning were shown to influence the results. These results are the first to associate GR SNPs with HSCT outcome and demonstrate the inherent problems of replicating SNP association studies in HSCT, due to different pre-transplant regimens.


    © 2018 John Wiley & Sons Ltd.

    KEYWORDS: chronic graft versus host disease, haplotype, inflammation aGVHD, polymorphisms, relapse

    Publikations ID: 30043490
    Quelle: öffnen
     
    Drucken
     
    ccc_logo_en.gif
    ccc_logo_en.gif
    ccc_logo_en.gif

    Schnellinfo

     
    -- Initiative Krebsforschung / Krebsforschungslauf

    -- Cancer Care
    -- Kliniken und Partner
    -- CCC Cancer School
    -- Young CCC
    -- CCC Tumorboards
    -- CCC Forschungscluster
    -- CCC Units
    -- CCC Platforms
    -- SOPs / Leitlinien
    -- Kontakt
    Zuklappen
     
    Ausklappen
     
     

    Featured

     
     
     
     
     
     
     
     
     
     
     
     
     
    © MedUni Wien |
     Impressum | Nutzungsbedingungen | Kontakt